This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Each month, an estimated 37 million packs of medicines are shipped between the EU and the UK, with 45 million traded in the opposite direction. This trade has been able to continue for the most part, as the UK’s regulator (the MHRA) remains aligned in many areas with the EU’s regulator (the EMA).
Brazilian pharmaproduction sites are involved in Covid-19 vaccine and therapy manufacture. There are a total of 43 manufacturing sites, most of which have approval from the Brazilian regulator ANVISA, but only 13 sites have FDA and/or EMA approval, showing an emphasis on domestic and regional production.
Prior to selling drugs or medical products in any country, pharmaceutical companies must prove compliance and gain the regulatory approval required by the country in which the goods will be distributed in. Regulatory requirements are in place to ensure medicines are safe for consumption. The dominion of data.
Until 2020, pharma had lagged other industries in its investment in digital marketing. In the US, TV advertising for pharmaproducts is still a big business, but this is mainly aimed at patients. A report from eMarketer came to an identical conclusion, estimating that US pharma would spend $9.53 This is an increase in 14.2%
A Wholesale Drug License is required when you want to sell medicines in bulk quantities. For example, through a PCD pharma franchise. When you want to sell medicines at a retail store, this license is required. The government, therefore, imposes rules and regulations to acquire a drug license. Retail Drug License.
Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content